Dopamine Agonists < Dopamine Antagonists < Dopamine D2 Receptor Antagonists

Facettes :

List of bibliographic references indexed by Dopamine Antagonists

Number of relevant bibliographic references: 29.
[0-20] [0 - 20][0 - 29][20-28][20-40]

Ident.	Authors (with country if any)	Title
000C50 (2013)	James B. Koprich [Canada] ; Philippe Huot ; Susan H. Fox ; Keith Jarvie ; Anthony E. Lang ; Philip Seeman ; Jonathan M. Brotchie	The effects of fast-off-D2 receptor antagonism on L-DOPA-induced dyskinesia and psychosis in parkinsonian macaques.
000C82 (2013)	S. Rios Romenets [Canada] ; Y. Dauvilliers ; V. Cochen De Cock ; B. Carlander ; S. Bayard ; C. Galatas ; C. Wolfson ; R B Postuma	Restless legs syndrome outside the blood-brain barrier--exacerbation by domperidone in Parkinson's disease.
000F54 (2013)	Ji Hyun Ko [Canada] ; Francesca Antonelli [Canada] ; Oury Monchi [Canada] ; Nicola Ray [Canada] ; Pablo Rusjan [Canada] ; Sylvain Houle [Canada] ; Anthony E. Lang [Canada] ; Leigh Christopher [Canada] ; Antonio P. Strafella [Canada]	Prefrontal dopaminergic receptor abnormalities and executive functions in Parkinson's disease
001F21 (2009)	T. D. L. Steeves [Canada] ; J. Miyasaki [Canada] ; M. Zurowski [Canada] ; A. E. Lang [Canada] ; G. Pellecchia [Canada] ; T. Van Eimeren [Canada] ; P. Rusjan [Canada] ; S. Houle [Canada] ; A. P. Strafella [Canada]	Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study
001F26 (2009)	Isabelle Boileau [Canada, Niger] ; Mark Guttman [Canada] ; Pablo Rusjan [Canada] ; John R. Adams [Canada] ; Sylvain Houle [Canada] ; Junchao Tong [Canada] ; Oleh Hornykiewicz [Autriche] ; Yoshiaki Furukawa [Canada] ; Alan A. Wilson [Canada] ; Shitij Kapur [Canada] ; Stephen J. Kish [Canada]	Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naïve Parkinson's disease
002322 (2008)	Yuhua Jiang [Canada, République populaire de Chine] ; Lin Pei [Canada] ; Shupeng Li [Canada] ; Min Wang [Canada] ; Fang Liu [Canada]	Extracellular dopamine induces the oxidative toxicity of SH‐SY5Y cells
002626 (2007)	Joseph Jankovic [États-Unis] ; Ray L. Watts [États-Unis] ; Wayne Martin [Canada] ; Babak Boroojerdi [États-Unis]	Transdermal rotigotine : Double-blind, placebo-controlled trial in parkinson disease
002706 (2006)	Antonio P. Strafella [Canada] ; Ji Hyun Ko [Canada] ; Oury Monchi [Canada]	Therapeutic application of transcranial magnetic stimulation in Parkinson’s disease: The contribution of expectation
002988 (2005)	Michel St-Hilaire [Canada] ; Eric Landry ; Daniel Lévesque ; Claude Rouillard	Denervation and repeated L-DOPA induce complex regulatory changes in neurochemical phenotypes of striatal neurons: implication of a dopamine D1-dependent mechanism.
002999 (2005)	Philip Seeman [Canada] ; Françoise Ko ; Matth Us Willeit ; Patrick Mccormick ; Nathalie Ginovart	Antiparkinson concentrations of pramipexole and PHNO occupy dopamine D2(high) and D3(high) receptors.
002A67 (2005)	Antonio P. Strafella [Canada] ; Ji Hyun Ko [Canada] ; Joshua Grant [Canada] ; Maria Fraraccio [Canada] ; Oury Monchi [Canada]	Corticostriatal functional interactions in Parkinson's disease: a rTMS/[11C]raclopride PET study
002D61 (2003)	Doris J. Doudet [Canada] ; James E. Holden	Raclopride studies of dopamine release: dependence on presynaptic integrity.
002F02 (2003)	Aviva Abosch [Canada] ; Shitij Kapur [Canada] ; Anthony E. Lang [Canada] ; Doug Hussey [Canada] ; Elspeth Sime [Canada] ; Janis Miyasaki [Canada] ; Svlvain Houle [Canada] ; Andres M. Lozano [Canada] ; Philip Starr ; Giovanni Broggi ; Roy A. E. Bakay ; Nicholas Boulis ; Ali R. Rezai	Stimulation of the subthalamic nucleus in Parkinson's disease does not produce striatal dopamine release. Commentary
002F66 (2002)	Raúl De La Fuente-Fernández [Canada] ; A Jon Stoessl	Parkinson's disease: imaging update.
003091 (2002)	Raul De La Fuente-Fernandez [Canada] ; Anthony G. Phillips [Canada] ; Mariangela Zamburlini [Canada] ; Vesna Sossi [Canada] ; Donald B. Calne [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada]	Dopamine release in human ventral striatum and expectation of reward
003109 (2001)	C. Zhang [Canada] ; J P Steiner ; G S Hamilton ; T P Hicks ; M O Poulter	Regeneration of dopaminergic function in 6-hydroxydopamine-lesioned rats by neuroimmunophilin ligand treatment.
003560 (2000)	E. F. Field [Canada] ; I. Q. Whishaw [Canada] ; S. M. Pellis [Canada]	Sex differences in catalepsy : evidence for hormone-dependent postural mechanisms in haloperidol-treated rats
003561 (2000)	Erich Mohr [Canada] ; Tilak Mendis [Canada] ; Kathleen Hildebrand [Canada] ; Peter Paul De Deyn [Belgique]	Risperidone in the treatment of dopamine-induced psychosis in Parkinson's disease: An open pilot trial
003619 (1999)	J A Barone [États-Unis]	Domperidone: a peripherally acting dopamine2-receptor antagonist.
003868 (1998)	P. Seeman [Canada] ; T. Tallerico	Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors.
003A70 (1997)	H. Shinotoh [Canada] ; B. Thiessen ; B J Snow ; S. Hashimoto ; P. Macleod ; I. Silveira ; G A Rouleau ; M. Schulzer ; D B Calne	Fluorodopa and raclopride PET analysis of patients with Machado-Joseph disease.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Dopamine Antagonists" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Dopamine Antagonists" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Dopamine Antagonists
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022